The Leuprolide Acetate Market growth is being propelled by an active clinical trial landscape that continues to validate new indications, combination strategies, and dosing paradigms for this well-established GnRH agonist. While leuprolide's efficacy in prostate cancer and endometriosis is firmly established, ongoing research is exploring its utility in breast cancer subsets, transgender...